1. Li, Zheng, Li, Yaming, Han, Dianwen, Zhao, Wenjing, Yang, Qifeng. 2023. circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells. In Cell death & disease, 14, 482. doi:10.1038/s41419-023-06006-5. https://pubmed.ncbi.nlm.nih.gov/37524698/
2. Miri, Kamelia, Latham, Keith, Panning, Barbara, Andersen, Angela, Varmuza, Susannah. 2013. The imprinted polycomb group gene Sfmbt2 is required for trophoblast maintenance and placenta development. In Development (Cambridge, England), 140, 4480-9. doi:10.1242/dev.096511. https://pubmed.ncbi.nlm.nih.gov/24154523/
3. Kuzmin, Anastasia, Han, Zhiming, Golding, Michael C, Latham, Keith E, Varmuza, Susannah. 2007. The PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues. In Gene expression patterns : GEP, 8, 107-16. doi:. https://pubmed.ncbi.nlm.nih.gov/18024232/
4. Hussain, Safdar, Sun, Mengyao, Min, Zixin, Sun, Jian, Lu, Shemin. 2018. Down-regulated in OA cartilage, SFMBT2 contributes to NF-κB-mediated ECM degradation. In Journal of cellular and molecular medicine, 22, 5753-5758. doi:10.1111/jcmm.13826. https://pubmed.ncbi.nlm.nih.gov/30133133/
5. He, Yuqi, Zhang, Zhongliang, Wang, Zinian, Kang, Qi, Li, Jingzhe. . Downregulation of circ-SFMBT2 blocks the development of gastric cancer by targeting the miR-885-3p/CHD7 pathway. In Anti-cancer drugs, 33, e247-e259. doi:10.1097/CAD.0000000000001195. https://pubmed.ncbi.nlm.nih.gov/34387601/